1-3 of 3
Brian West, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recurrent Mutations in CCND3 Confer Clinical Resistance to FLT3 Inhibitors

Catherine C. Smith, MD, Aaron D. Viny, MD MS, Evan S. Massi, BS, Cyriac Kandoth, PhD, Nicholas D. Socci, PhD, Henry Hsu, MD, Brian West, PhD, Gideon Bollag, PhD, Barry S. Taylor, PhD, Ross L. Levine, MD, Neil P. Shah
Journal: Blood
Blood (2015) 126 (23): 677.
https://doi.org/10.1182/blood.V126.23.677.677
Published: 2015
Journal Articles

The Combination of PLX3397, a Selective FLT3-ITD Inhibitor, and Decitabine, a Hypomethylating Agent, Demonstrates Benefit in AML Cell Lines in Vitro and in Vivo

James Tsai, Elizabeth A Burton, PhD, Gaston Habets, PhD, Brian West, PhD, Paul Lin, MD, Henry Hsu, MD, Chao Zhang, PhD, Gideon Bollag, PhD
Journal: Blood
Blood (2014) 124 (21): 3743.
https://doi.org/10.1182/blood.V124.21.3743.3743
Published: 2014
Journal Articles

Novel Germ Line Mutations in the KRAS2 Gene Cause Noonan Syndrome and Deregulate Hematopoietic Cell Growth.

Suzanne Schubbert, Martin Zenker, MD, Sara L. Rowe, Silke Bòˆll, Cornelia Klein, Ineke van der Burgt, MD, Luciana Musante, PhD, Hoa Nguyen, Brian West, PhD, Gideon Bollag, PhD, Charlotte M. Niemeyer, MD, Kevin M. Shannon, MD, Christian P. Kratz, MD
Journal: Blood
Blood (2005) 106 (11): 1602.
https://doi.org/10.1182/blood.V106.11.1602.1602
Published: 2005